Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


Jobs go as Covid hits iNova

Posted 13 October 2020

iNova Australia is restructuring as the impact of Covid and other factors force the business to "re-balance" in order to meet what it says are "future market dynamics and challenges", the company announced on Monday.

iNova gathered its 185 Australian staff in a Town Hall meeting on Monday to inform them of the changes, and while new roles will be added to the business, the net result will be a smaller organisation.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
How much to save the kid?
We paid a high price for our elderly so what about children
Special Report
Aust Covid Vaccine Tracker
UPDATES: Sanofi/GSK sign Statement of Intent with Gavi; Aust to import 3.8m vax doses
Approvals Action
Novartis' triplet inhaler ticked
First-in-class maintenance treatment of asthma